Tocilizumab is already being used by some rheumies for PMR as well as GCA where it has been approved internationally. But it is very expensive so use for PMR is probably not likely to happen.
But as I understand the article - rituximab is for GPA and I think it is already being used for a few forms of vasculitis anyway. And as for describing tocilizumab as a "less toxic therapy" - hum!
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.